Therapy for each breast cancer patient
needs to be optimized to avoid the delays,
side-effects, and costs of ineffective treatments.
PET/X combines PET (positron emmision
tomography and X-ray mammography to
quickly and reliably determine which targeted
breast cancer therapies will be effective for each patient.
PET/X is also valuable for testing efficacy in
newly developed treatments in clinical trials.
Our instrument is currently under development for.
research use only. It is not FDA approved.